USCA RIA’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$1M Buy
10,842
+3,755
+53% +$319K 0.06% 306
2021
Q1
$629K Buy
7,087
+3,072
+77% +$305K 0.04% 348
2020
Q4
$374K Buy
+4,015
New +$320K 0.03% 376

Other funds holding ARKG

USCA RIA's ARKG Position: Q2 2021 in Review

USCA RIA increased its ARK Genomic Revolution ETF (ARKG) stake by 53% in Q2 2021, buying an estimated $319K and bringing the position to 10,842 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #306.

USCA RIA first reported a position in ARKG in Q4 2020 and has held it in 3 quarters since. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • USCA RIA held 10,842 shares of ARK Genomic Revolution ETF worth $1M as of Q2 2021.
  • USCA RIA bought 3,755 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $319K.
  • ARK Genomic Revolution ETF made up 0.06% of USCA RIA's portfolio in Q2 2021, its #306 holding.
  • USCA RIA first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 3 quarters since.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.